Related Experiment Video
Updated: Jun 24, 2026

Adapting Taylor Dispersion to Measure the Dispersion Coefficient of Electrolyte Solutions via an Accessible Microfluidic Setup
Published on: October 7, 2025
Importance of Taylor dispersion in pharmacokinetic and multiple indicator dilution modelling
Marissa S Fallon1, Brett A Howell, Anuj Chauhan
1Department of Chemical Engineering, PO Box 116005, University of Florida, Gainesville, FL 32611, USA.
Abstract:
Mass transfer in tissues is typically studied by multiple indicator dilution (MID) studies. Several of these studies have shown that drug concentrations can be modelled by axially distributed models. In this paper, we determine the Taylor dispersion coefficient that describes the degree of axial mixing for the MID models, while accounting for the presence of red blood cells in the capillaries. The capillaries are treated as well mixed with no radial concentration gradients. The concentration in tissue is treated as position and time dependent and the partial differential equations for mass transport are averaged using the method of multiple timescales. The calculated values of the dispersion coefficient are in reasonable agreement with the values reported in literature, suggesting that Taylor dispersion is an important contributor to dispersion in tissues. We also show that the average equations for the barrier-limited drugs reduce to the commonly used Sangren-Sheppard model. In this case, Taylor dispersion is not significant in comparison to the dispersion caused by drug exchange between the capillary and the tissue. Additionally, we utilize the average equations for both flow-limited and barrier-limited drugs in pharmacokinetic models. These simulations show that neglecting the dispersion coefficient could cause significant effects in the dynamic drug concentration profiles and thus lead to incorrect estimation of parameters if the experimental data from MID studies are fitted to a model that neglects Taylor dispersion.
Related Concept Videos
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacodynamic Models: Linear Concentration–Effect Model
Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

